Phibro Animal Health Corp. (PAHC) Social Stream
PHIBRO ANIMAL HEALTH CORP (PAHC) Price Targets From Analysts
Use the tables below to see what analysts covering PHIBRO ANIMAL HEALTH CORP think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-03 | 2 | $23 | $17 | $20 | $12.92 | 54.8% |
| 2021-11-18 | 3 | $23 | $17 | $21 | $12.92 | 62.54% |
| 2022-02-11 | 3 | $23 | $17 | $21 | $12.92 | 62.54% |
| 2022-05-06 | 3 | $23 | $18 | $21.333 | $12.92 | 65.12% |
| 2022-08-13 | 3 | $23 | $18 | $21 | $12.92 | 62.54% |
| 2022-09-10 | 3 | $22 | $16 | $19.666 | $12.92 | 52.21% |
| 2022-09-17 | 3 | $21 | $16 | $18 | $12.92 | 39.32% |
| 2022-10-26 | 3 | $21 | $14 | $17.333 | $12.92 | 34.16% |
| 2022-11-09 | 3 | $20 | $14 | $17 | $12.92 | 31.58% |
| 2022-11-17 | 3 | $20 | $12 | $16.333 | $12.92 | 26.42% |
| 2023-02-08 | 4 | $20 | $12 | $16.75 | $12.92 | 29.64% |
| 2023-02-09 | 4 | $21 | $12 | $17.25 | $12.92 | 33.51% |
| 2023-05-04 | 4 | $21 | $12 | $17 | $12.92 | 31.58% |
The Trend in the Analyst Price Target
Over the past 22 months, PAHC's average price target has gone down $5.
Over the past 40 weeks, PAHC's average upside potential has been 17.7%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-08-26 | 3 | 22 | 16 | 19.666 | 15.99 | 22.99% |
| 2022-11-09 | 3 | 20 | 14 | 17.000 | 14.42 | 17.89% |
| 2022-12-21 | 4 | 20 | 12 | 16.750 | 13.67 | 22.53% |
| 2023-01-27 | 4 | 20 | 12 | 16.750 | 15.25 | 9.84% |
| 2023-02-09 | 4 | 21 | 12 | 17.250 | 15.90 | 8.49% |
PAHC Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3.25 | 1 | 0 | 1 | 1 | 1 | 4 |
The Trend in the Broker Recommendations
Over the past 33 months, PAHC's average broker recommendation rating worsened by 0.08.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PAHC as an investment opportunity.
- PAHC has a greater number of analysts covering the stock than 130.86% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, PHIBRO ANIMAL HEALTH CORP's average analyst price target is higher than 299.07% of them.
- In terms of how PHIBRO ANIMAL HEALTH CORP fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -209.73% of that group.
- In terms of how PHIBRO ANIMAL HEALTH CORP fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 350.43% of that group.
In the Pharmaceutical Products industry, SAGE, FGEN, and TARO are the three stocks most similar to PHIBRO ANIMAL HEALTH CORP regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is PAHC a Buy, Hold or Sell? See the POWR Ratings now!